US Bancorp’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
2015
Q1
$110K Sell
2014
Q4
$112K Buy
2014
Q3
$65K Buy
2014
Q2
$91K Buy